Scandion Oncology A/S

    Scandion Oncology A/S

    SSTO:SCOL
    - -
    SEK
    - -
    - -
    Scandion Oncology A/S
    STO:SCOL
    (Nasdaq Stockholm)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    DKK
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    - -
    -0.24
    -0.25
    -0.16
    -0.49
    -0.57
    -0.96
    -0.16
    -0.17
    Basic EPS, GAAP
    - -
    -0.39
    -0.21
    -0.16
    -0.47
    -0.52
    -1.24
    -0.12
    -0.13
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    -0.25
    -0.4
    -0.33
    -0.82
    -1.21
    -4.96
    -0.96
    -1.06
    Book Value per Share
    - -
    0.37
    0.37
    1.47
    0.99
    0.52
    0.76
    0.04
    0.04
    Tangible Book Value per Share
    - -
    34
    50
    106
    106
    134
    41
    235
    212
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    1
    1
    1
    - -
    1
    Depreciation Expense
    - -
    -8
    -12
    -17
    -52
    -77
    -39
    -37
    -37
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    1
    13
    18
    156
    103
    69
    30
    8
    8
    Working Capital
    - -
    - -
    - -
    - -
    1
    1
    - -
    - -
    - -
    LT Debt
    1
    13
    18
    156
    105
    70
    31
    8
    8
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    DKK

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    232
    232
    235
    Market Capitalization
    30
    18
    10

    Working Capital

    DKK

    •

    in mil. unless spec.
    Jun'24
    Sep'24
    Dec'24
    Total Current Assets
    34
    23
    18
    Cash, Cash Equivalents & STI
    27
    15
    13
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    8
    5
    10
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    DKK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    111.03%
    -73.43%
    Free Cash Flow
    - -
    45.16%
    -45.69%
    Net Income, GAAP
    - -
    47.06%
    -6.49%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    DKK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    DKK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.12
    -0.22
    -0.19
    - -
    -0.57
    2023
    -0.07
    -0.07
    -0.08
    -0.08
    -0.96
    2024
    -0.06
    -0.03
    -0.03
    -0.06
    -0.16

    Quarterly Dividends Per Share

    DKK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business